Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MPI | P34949 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Demannose SCHEMBL3904983 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL6750831 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Galactose SCHEMBL14856251 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL8528284 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Galactose SCHEMBL1548813 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL22712624 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL6055085 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL2799182 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL20817166 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL1858493 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1PDE4AAKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250288601-A1 | METHODS FOR TREATING UROGENITAL HEALTH CONDITIONS | ONE BIO INC (US) | 2025-09-18 | — | — | US | claimed |
| EP-4522124-A2 | METHODS FOR TREATING UROGENITAL HEALTH CONDITIONS | One Bio Inc (US) | 2025-03-19 | — | — | EP | claimed |
| WO-2023220318-A2 | METHODS FOR TREATING UROGENITAL HEALTH CONDITIONS | BCD BIOSCIENCE, INC. (US) | 2023-11-16 | — | — | WO | claimed |
| CN-116445305-A | Marine fungus for producing squalene by utilizing xylose and application thereof | 中国科学院青岛生物能源与过程研究所 | 2023-07-18 | — | — | CN | claimed |
| CN-109744362-B | Mixed feed additive for tilapia | 浙江海洋大学 | 2022-03-29 | — | — | CN | claimed |
| CN-113475630-A | Method for preparing flavoring agent for cats by using Maillard reaction intermediate | 江苏翼邦生物技术有限公司 | 2021-10-08 | — | — | CN | claimed |
| CN-105815176-B | A kind of production method of selenium-enriched health care tealeaves | 云南欣确生物科技有限公司 | 2019-03-05 | — | — | CN | claimed |
| CN-109239160-A | A kind of glucose sensor of Novel free xylose interference | 江苏鱼跃医疗设备股份有限公司 | 2019-01-18 | — | — | CN | claimed |
| CN-108740818-A | A kind of preparation method of fermentation duck leg | 宁波大学 | 2018-11-06 | — | — | CN | claimed |
| CN-104982972-B | A kind of method of the bioanalysis control excessive lipid oxidation of cured fish process | 中国水产科学研究院南海水产研究所 | 2018-08-21 | — | — | CN | claimed |
| CN-103948530-B | A kind of precious Rogor moisture-keeping composition and preparation method thereof | 广州雅纯化妆品制造有限公司 | 2016-06-15 | — | — | CN | claimed |
| US-20150344532-A1 | ENGINEERED XYLOSE TRANSPORTERS WITH REDUCED GLUCOSE INHIBITION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2015-12-03 | — | — | US | claimed |
| WO-2015179701-A1 | ENGINEERED XYLOSE TRANSPORTERS WITH REDUCED GLUCOSE INHIBITION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-11-26 | — | — | WO | claimed |
| CN-104982972-A | Method for controlling excessive lipid oxidation in fish salting and drying processes through biological method | SOUTH CHINA SEA FISHERIES RES | 2015-10-21 | — | — | CN | claimed |
| CN-104721301-A | Apple polyphenol ethanol extract as well as preparation method and application thereof | MEDICAL COLLEGE CAPF | 2015-06-24 | — | — | CN | claimed |
| CN-103269673-A | Fluid composition comprising a structuring agent | COLGATE PALMOLIVE CO | 2013-08-28 | — | — | CN | claimed |
| CN-101255446-B | Method for continuous fermentation of glucose xylose by coupling immobilized yeast cell and pervaporation membrane | UNIV DALIAN TECH | 2010-09-29 | — | — | CN | claimed |
| CN-101255446-A | Method for continuous fermentation of glucose xylose by coupling immobilized yeast cell and pervaporation membrane | UNIV DALIAN TECH (CN) | 2008-09-03 | — | — | CN | claimed |
| CN-1205907-C | Cosmetic composition containing polysaccharide and tripolymer of acrylic acid and its use for protecting cuticles | OREAL (FR) | 2005-06-15 | — | — | CN | claimed |
| CN-1243698-A | Cosmetic composition containing polysaccharide and tripolymer of acrylic acid and its use for protecting cuticles | OREAL (FR) | 2000-02-09 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344532-A1 | ENGINEERED XYLOSE TRANSPORTERS WITH REDUCED GLUCOSE INHIBITION | SLC2A1, SLC2A8, SLC2A4 | LMNA 4684/4885L3MBTL1 1329/4885TDP1 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.